The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2023
Filed:
Aug. 02, 2019
Applicants:
The University of Tokyo, Tokyo, JP;
Hanavax Inc., Tokyo, JP;
Inventors:
Assignees:
THE UNIVERSITY OF TOKYO, Tokyo, JP;
HANAVAX INC., Tokyo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 47/54 (2017.01); A61P 37/04 (2006.01); A61P 31/20 (2006.01); A61P 31/14 (2006.01); A61P 31/06 (2006.01); A61K 39/04 (2006.01); A61K 39/12 (2006.01); A61K 39/155 (2006.01); A61K 39/39 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6903 (2017.08); A61K 39/04 (2013.01); A61K 39/12 (2013.01); A61K 39/155 (2013.01); A61K 39/39 (2013.01); A61K 47/549 (2017.08); A61P 31/06 (2018.01); A61P 31/14 (2018.01); A61P 31/20 (2018.01); A61P 37/04 (2018.01); C12N 7/00 (2013.01); A61K 2039/55561 (2013.01); C12N 2710/20034 (2013.01); C12N 2760/18534 (2013.01);
Abstract
The present invention provides a nanogel nasal vaccine that induces cell-mediated immunity. The present invention relates to a vaccine preparation comprising a complex of a nanogel, a vaccine antigen, and an adjuvant, wherein the vaccine preparation can efficiently induce the cell-mediated immunity, and can also induce a systemic and mucosal immune response.